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Robin Irvine
The pleckstrin homology (PH) domains of a number of
proteins have been found to interact in vitro with
inositol phospholipids; recent experiments show that
these interactions may be important in directing protein
translocation to specific parts of the cell following
stimulus-induced lipid breakdown or synthesis.
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“Location, location, location...” is reputedly the creed by
which real-estate agents value property, and as we learn
more about the players in cellular signalling we see that a
similar philosophy pervades this business too. Many
proteins, such as protein kinases, are increasingly being
seen to be taken to the right place at the right time by
targeting or scaffold proteins, whose location or ability to
bind other proteins can in turn be regulated in complex
ways. Because phospholipids generally remain in the
membrane in which they were synthesised, at least for a
reasonable time, it is not surprising that an emerging
number of physiological processes are controlled, either
primarily or entirely, by the translocation of a signalling
protein following a stimulus-induced change in the
metabolism of a phospholipid — in the context of this
review, an inositol lipid.
PLCd and PIP2
Phospholipase C δ1 (PLCδ1) has as its aim in life the
hydrolysis of phosphatidylinositol 4,5-bisphosphate
(PIP2), so obviously the enzyme must interact with that
lipid at some point. But PLCδ1 has several distinct
binding sites for PIP2 [1], of which the highest affinity one
is its pleckstrin homology (PH) domain, which binds
specifically to the inositol 1,4,5-trisphosphate headgroup
of PIP2 [2]. This interaction has recently been exploited in
an elegant manner by Stauffer et al. [3] as a way of investi-
gating where PIP2 is located in cells — although PIP2 has
generally been assumed to be predominantly in the
plasma membrane, direct evidence for this has been diffi-
cult to come by. 
Stauffer et al. [3] transfected cells with a DNA construct
encoding the PH domain of PLCδ1 linked to green fluores-
cent protein (GFP). They found that the fluorescent fusion
protein did indeed predominantly localise to the plasma
membrane. Moreover, activation of a PLC-linked receptor
caused translocation of the fusion protein to the cytosol,
consistent with a stimulus-induced decrease in the plasma
membrane PIP2 level. That said, there is a complication in
the quantification of this PIP2 decrease; it is known that
inositol 1,4,5-trisphosphate (IP3) itself binds tightly to the
PLCδ1 PH domain, and indeed, IP3 can compete with
PIP2 well enough to act as a competitive inhibitor of the
enzyme, at least in vitro [4]. Some of the translocation of
the construct from the plasma membrane may thus repre-
sent competition by IP3 as well as removal of PIP2.
But whatever the underlying mechanism, this is a very
useful single cell assay for PLC activation. The assay is
quite specific for PLC — removal of PIP2 by phospho-
inositide 3-kinase (PI 3-kinase) would not release the
PLCδ1 PH domain, as the PI 3-kinase reaction product,
phosphatidylinositol 3,4,5-trisphosphate (PIP3), binds to
the PLCδ1 PH domain with an affinity similar to PIP2. It
is also, especially in the form of a ‘movie’ made from the
data, a most elegant and pleasing real-time visualisation in
a living cell of a reaction that was first observed indirectly
in tissue slices nearly fifty years ago [5].
PIP3
PIP3 is the most obviously promising inositol lipid to
cause a translocation of target proteins — the parallels
with the well-known translocation of protein kinase C in
response to the generation of diacylglycerol by PIP2
hydrolysis are obvious. This idea has been strengthened
by the growing realisation that a number of PH domains
bind PIP3 with a high affinity and specificity [6,7], and
this has made it likely that these proteins are regulated by
PIP3. One such protein is ARNO, a guanine nucleotide
exchange factor for the small GTPase ADP-ribosylation
factor (ARF). ARNO binds to PIP3 with an impressive
degree of specificity, as do two other proteins with very
similar PH domains, Grp1 and cytohesin-1 [7]. (Note that,
because there are more inositol phosphate isomers avail-
able than inositol lipids, the specificity of binding is often
explored in detail using inositol 1,3,4,5-tetraphosphate
(IP4), the headgroup of PIP3; this has a further relevance
discussed below.)
The same technique of using GFP-tagging to give real-
time images of protein translocation has recently been
used to show directly that ARNO does indeed move to the
plasma membrane from the cytosol in response to a PIP3-
generating signal, and then falls off again into the cytosol
if PIP3 production is inhibited [8]. As with the PLCδ1 data
described above, the movie makes the translocation
remarkably impressive — especially if speeded up to the
sound of honky-tonk music, a way in which the authors
have been known to present the data at meetings! Similar
data have been obtained with the PH domains of Grp1
and cytohesin-1 (P.J. Cullen, personal communication),
which confirms that these proteins too are likely to be reg-
ulated by PIP3, at least to the extent of being translocated
to the plasma membrane.
Protein kinase B
There are, not surprisingly, complications to this simplis-
tic summary. Is this mode of regulation by PIP3 going to
be confined to proteins whose function lies in the plasma
membrane — put another way, is PIP3 ever generated in
other places in the cell, and if so, how does the cell ensure
the right proteins go there? And is translocation the whole
story, or are other control mechanisms involved? The
answer to the second question is apparently that other
mechanisms are involved, at least as far as the regulation
of protein kinase B (PKB, also known as Akt) is con-
cerned. PKB is one of the most intensively studied of the
putative targets of the PI 3-kinase system, and its regula-
tion has proved a complex issue, much of which lies
beyond the scope of this article — for example, the extent
to which phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2)
contributes to its regulation independently of PIP3, and
the corollary of whether PI(3,4)P2 is synthesised indepen-
dently of PIP3, are both unresolved issues, and I shall
ignore them in this context.
The key issue here is that PKB has a PH domain that
binds 3-phosphorylated inositol lipids, and its transloca-
tion to the plasma membrane is an important part of its
activation [9]. But this is not the whole story of its regula-
tion, in that it is also phosphorylated by a PIP3-activated
phosphoinositide-dependent protein kinase (PDK-1,
probably one of a family [10]), which in turn has a PH
domain that binds PIP3 [11,12]. Stokoe et al. [12] most
clearly dissected out the two independent contributions of
3-phosphorylated inositol lipids to the activation of PKB,
on PDK-1 and on PKB itself. So does PDK-1 also translo-
cate to the plasma membrane when PI 3-kinase is stimu-
lated? Anderson et al. [13] have shown recently that
indeed it does, that PDK-1’s PH domain is essential for
this process, and that the translocation of PDK-1 is an
essential part of the way in which it activates PKB. 
BTK and PLCg
One of the best known PIP3-binding proteins is Bruton’s
tyrosine kinase (BTK). This protein kinase is an essential
component of the B-cell proliferation pathway that is stim-
ulated by activation of the B-cell receptor, as revealed by
an absence of this proliferation in humans or mice that
have a mutation in BTK [14–16]. The PH domain of BTK
binds PIP3 with a high degree of headgroup specificity.
The structure of this PH domain has been solved, and this
has led to a precise model for its probable interaction with
the IP4 headgroup of PIP3 [14]. One of the proposed
downstream targets for BTK is PLCγ2 (with possibly
some activation of PLCγ1) [15,16], which provides a novel
and direct link between the PI 3-kinase and PLC
branches of inositide signalling, and is probably the route
by which the B-cell receptor activates IP3 synthesis and
thus Ca2+ entry into the cell.
But Falasca et al. [17] have found a remarkable extra level
of PIP3 involvement in this signalling pathway, which
echoes strongly the dual role of PIP3 in PKB activation
mentioned above. The PH domain of PLCγ does not bind
PIP2 with the same specificity as PLCδ1, but rather it
shows a binding preference for PIP3. Moreover, Falasca et
al. [17] have shown, once again by GFP tagging, that
PLCγ1 translocates to the plasma membrane in response
to a PIP3 signal, and that PIP3 binding by the enzyme is
an important component of its activation. So, as with PKB
and PDK-1, it may be that a protein kinase (BTK) and its
substrate (PLCγ) are both translocated, independently but
coincidentally, to the plasma membrane by virtue of their
PIP3-binding PH domains (Figure 1). As Falasca et al. [17]
point out, this requirement for PIP3-stimulated transloca-
tion of PLCγ may be an explanation for what has up to
now been a puzzling inconsistency in several experimen-
tal systems between the extent of the tyrosine phosphory-
lation of PLCγ and its activation.
GAP1IP4BP and GAP1m
Two other proteins with PH domains that have been
shown to bind PIP3 and IP4 with a remarkable specificity
are GAP1m and GAP1IP4BP, both members of the GAP1
family of Ras GTPase-activating proteins [18,19].
However, current evidence suggests that they may be
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Figure 1
Activation of phospholipase C γ (PLCγ) by BTK. This figure illustrates
schematically how the PLC pathway can be activated in B cells by the
product of the PI 3-kinase pathway — PIP3. The formation of PIP3 in the
plasma membrane — in turn caused by activation of B-cell receptors —
causes both BTK and PLCγ to translocate there, so that the former can
phosphorylate the latter, on tyrosine residues, and thus activate it. This
leads to PIP2 hydrolysis and the formation of IP3 and diacylglycerol.
















involved more in the signalling pathway of PLC than that
of PI 3-kinase. As far as the pharmacology of binding has
been studied, they appear to differ from the proteins dis-
cussed above. For example, ARNO [8], Btk, Grp-1 and
cytohesin-1 (P.J. Cullen, personal communication) all bind
diacetyl-PIP3 or Gro-PIP3 with an affinity similar to or
even greater than IP4, whereas GAP1IP4BP ‘prefers’ IP4
over diacetyl-PIP3 or Gro-PIP3 by at least an order of mag-
nitude (see [18]). (Comparing water-soluble PIP3 deriva-
tives with IP4 is far from ideal, but it is the only
quantitatively meaningful way of getting at this question
because of the difficulty of interpreting data comparing a
lipid and an inositol phosphate in an aqueous solution.) 
This, plus other indirect pieces of evidence [18] and more
direct data [20] implicating GAP1m and GAP1IP4BP in the
connection between IP3 and Ca2+ homeostasis, could be
argued as pointing towards IP4 as a more likely ligand for
the control of these GAP1 proteins in vivo — they look
more like IP4 receptors than PIP3 receptors. So it is partic-
ularly interesting that recent evidence [19] has suggested
that, in apparently unstimulated cells, these proteins are
mostly in the perinuclear endoplasmic reticulum (GAP1m)
or the plasma membrane (GAP1IP4BP), and that at least for
GAP1IP4BP the location is governed in part by the PH
domain. We are learning a lot about PH domains that inter-
act with inositides [7], but we still have a long way to go.
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